Related content

Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study

By Recker R.   Weinstein R.   Chesnut C.   Schimmer R.   Mahoney P.   Hughes C.   Bonvoisin B.   Meunier P.  

Osteoporosis International, Vol. 15, Iss. 3, 2004-03 ,pp. : 231-237

Springer Publishing Company

Access to resources Recommend Favorite

Changes in bone mineral density, bone turnover markers, and vertebral fracture risk reduction with once weekly teriparatide

By Tanaka Shiro   Kuroda Tatsuhiko   Sugimoto Toshitsugu   Nakamura Toshitaka   Shiraki Masataka  

Current Medical Research and Opinion, Vol. 30, Iss. 5, 2014-05 ,pp. : 931-936

Informa Healthcare

Access to resources Recommend Favorite

Prospective Identification of Postmenopausal Osteoporotic Women at High Vertebral Fracture Risk by Radiography, Bone Densitometry, Quantitative Ultrasound, and Laboratory Findings: Results From the PIOS Study

By Glüer Maren Gesina   Minne Helmut W.   Glüer Claus-Christian   Lazarescu A. Doina   Pfeifer Michael   Perschel Frank H.   Fitzner Rudolf   Pollähne Wolfgang   Schlotthauer Tamara   Pospeschill Markus  

Journal of Clinical Densitometry, Vol. 8, Iss. 4, 2005-12 ,pp. : 386-395

Humana Press, Inc

Access to resources Recommend Favorite

Comparison of Biochemical Markers of Bone Turnover and Bone Mineral Density Between Hip Fracture and Vertebral Fracture

By Takahashi Masaaki   Naitou Kenichi   Ohishi Tsuyoshi   Nagano Akira  

Journal of Clinical Densitometry, Vol. 6, Iss. 3, 2003-09 ,pp. : 211-218

Humana Press, Inc

Access to resources Recommend Favorite

Relationship Between Phalangeal Bone Density and Risk of Vertebral Fracture

By Ohtsuka M.   Michaeli D.   Wasnich R.D.  

Journal of Clinical Densitometry, Vol. 5, Iss. 1, 2002-03 ,pp. : 11-16

Humana Press, Inc

Access to resources Recommend Favorite